{"name":"Heartseed Inc.","slug":"heartseed-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE9NUVdvYmtVd2VYV2p5ZGJzc1hIT3oxUWM4Z3dJMXpiQy1DQVVuWmZnVmM1MmRDM3FRenY4cUstTGhlTWZZZ25XUEpzN3YtZ3hZanQzT1RXTFI3OXY5QkxhbjlUc0FyMU1icTlsclIwYkxUeE5BX2fSAXtBVV95cUxPQU1taENRUWNEQ29za2Zzd05Kb08yaHo2eWNULVkxYzJ3aGZPVWJkczVKdlJjOWM5bGJWS2Y1WjVSOENlSWcwWWY1YzdTMFEtS042QndaRjFQTEZrcWNBdEFycXNCNVNkRmRSUFlHMlhKMjVycFVKSG92a3M?oc=5","date":"2025-12-24","type":"deal","source":"BioInformant","summary":"Novo Nordisk Ends $598M Heartseed Partnership to Refocus Strategic Priorities - BioInformant","headline":"Novo Nordisk Ends $598M Heartseed Partnership to Refocus Strategic Priorities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPejFlVktURTNWeFc1YXE3UmluLV9NVTRtSUlRWXVyZTVvb29LUkVKQS1KVnhsU3hsVnk3QVVNTjlZeVp0NjZzU2h3bEl4Y0lKMzdub25ramJ2d3lfY0NxbXI4b0RpZ05yV3lQbzR6ZVAwanc1VTAwUGlyTFJMbndmd2VJRkk4aU9wa29vTFQzNXowU0tSLWJyOVBfQm9iYXRTTmhFdWl6c3VUVFNlY3dRbEZPUXBRdElfN1E?oc=5","date":"2025-09-30","type":"deal","source":"Fierce Biotech","summary":"Novo dumps cell therapy partner Heartseed, calling off $598M collab amid restructuring - Fierce Biotech","headline":"Novo dumps cell therapy partner Heartseed, calling off $598M collab amid restructuring","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQUHpMbFFrTEpaOGI0VW5sTE5ldzZsMDNpdVJvam1fWEk5aTFSMFdqUUhqYVlhT3VmSERFTXlHajEtM3NzeFljQkpRS1EwVHZCdWU2TXRIMzlsM25SU0pZZC03SjhFRy1lQ082VUxCUnNfMFJ5dDUyRVhKNnFqdTNXaC1NLWxtWVlVcTIzbEQ5SERSNEF4aG1nQW1Bb1JLQ2dINF9V?oc=5","date":"2025-09-30","type":"deal","source":"BioWorld News","summary":"Novo ends Heartseed deal for iPS cell-derived cardiomyocytes - BioWorld News","headline":"Novo ends Heartseed deal for iPS cell-derived cardiomyocytes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5EbEZXNmloNFctTWkxNTk5ZXkzWF9FWm5sZVFhVzRWTmtVUFhBT3dySkV2eEFzZDUtLXNwZm11djdaQXdyR2RSZWdzMVF3dV9tWDduT1J3OV9hRmZTVUNONVNvNlU4UlRUX3EtSWg1MGxQT2xqRzNQMG4zbw?oc=5","date":"2024-02-27","type":"pipeline","source":"Labiotech.eu","summary":"Japan’s ten hottest biotech companies in healthcare - Labiotech.eu","headline":"Japan’s ten hottest biotech companies in healthcare","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTFB0a19DaHhaWnlLVUpSeHBFc2gxTC1oM1g2ZDdFM3VlVjhzWlN1VTJyM1U0bjc3cTYtY1VqTXFyN3BTSnBjSWZHWEJxa0tmS1RHRTA2cUN2cG9ZbnNOenJyT1dyVWhJUUM4ZHBpS2x1cHRFd9IBd0FVX3lxTE9wVGVsbUpwa3d4M1U0a215Z3laZGctODUtMEtOd0pKU1FjWl90Q3FvOFVsNE9IVGFLYkdhellyRTVGcnBhUFVrTEJJaG9uNVRQSzRFRlhOR2Z5TGt6VkRXV3VpOWl5V2NKZ1RzMzRKM0RxRzN3QnV3?oc=5","date":"2023-11-02","type":"pipeline","source":"BioInformant","summary":"Using iPS Cells from I Peace, Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes, A Major Step Forward in Advancing Autologous Cardiac Regenerative Medicine - BioInformant","headline":"Using iPS Cells from I Peace, Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes, A Major Step Forwar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwJBVV95cUxPck9qT0psT2laNzlXei14SjRQQzZzRG9YSjQyRllhMlVycGxPSVR2d2lkRlF5TjBrb1psVFB5dFVhV3MzSzZHOFZGbUk0VHl6X1RJUGUzc00yVHJidnFrMWFOQ0NMSW9BQThhWEhNbDZSYUZySmpZMW9OWk1QbnJ1QWd5aDA4T08xVVRhcWN0OFhjVk9IYnd0Q0JxTlc2UWI5UHVDdWNQcjNvSGJaUlllOWd0dUoxUElVZWE5dE1KdkJHUXdrS3hvNUszVmpEaW1BdHRkOTlnVTlmWlV3VVl0UlRSY2RPS2lpQXhxUUhiMTZfaHl2YklySTRtMnpUeW94anhENGlIUXpuaWtrMi0tQVFkdU9pVm5ldFhJTzdDOEZabmM5bEZxLUJvU1FGOFlrazhQTG5pSUZINHdfd3RiQVVrZlhnNVJOVlVXb1Ewcw?oc=5","date":"2023-11-01","type":"pipeline","source":"Business Wire","summary":"Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes Using iPS Cells from I Peace, A Major Step Forward in Advancing Autologous Cardiac Regenerative Medicine - Business Wire","headline":"Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes Using iPS Cells from I Peace, A Major Step Forward","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPQmc5eWprcno2U2tmQnk3V0RRaTdXR1RUcWdwelNrVjJNc1VUWG95SzVRYTRPSTVGOEVnQWNnWnRYRGlHY1d6OHA3MlhkVlA5blpDQ1lzM0tvM19kZHlOakpqLWJtVUhBZTRxSWF1aVd6MHcteWhDYTVaT3BPWXIzeDh3WUE4LW1leEE?oc=5","date":"2023-02-10","type":"pipeline","source":"pharmaphorum","summary":"Heart hope for Heartseed/Novo Nordisk HS-001 cell therapy - pharmaphorum","headline":"Heart hope for Heartseed/Novo Nordisk HS-001 cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOakNyM2kxWHE4UHVzS25TVERLOEdxMHY1azRZaUkwLWRSeks4Z0phYkNhcFZLdTNxaFBBRWtZS1Vwb3R5c2NyRC1FQzJsS0EzY0xDOGdNSndHR3AwNUc0T1RWc1IxWUwxaFhsT0dqX2wyeEZNckh6b1dKcDZEY0EtUzl4REJWSzZ3aHU1OV85RHFpR0lQdjd4LUNPcGhoYkhVNC1ZTzl5WWE?oc=5","date":"2020-09-15","type":"pipeline","source":"Business Wire","summary":"Mutsuki Takano Was Appointed as CFO at Heartseed - Business Wire","headline":"Mutsuki Takano Was Appointed as CFO at Heartseed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPNjdmMHZ2eGFyRFdVeFZXM1puT2R3NEk0Qkh5dHZTWnEtVC1YV05sMG1fVU9TVlVnbGU2LVZGUFFNNjRXNTNyV21vc2JyY1JHRXNUZmV1Q3JtX3hBX09odGtqSjdCLXhJVDAwMDdOSEtIOGZxYWFCaHZkdmswbU1RNnRHNUxfX2N0amtuYXRGeEVXN1IzYkdJT3YzRW43eWNiTlZ1dUw3ek9td0ZrRFJKMVc2dndGdTYwUTlxTXdVdFNxcGxISER4bnBobmI0a3hZY2pGbG40a1d4eEUwVHFrZA?oc=5","date":"2019-11-22","type":"pipeline","source":"BioSpace","summary":"Heartseed Raises $26M in Series B Funding to Accelerate Development of iPSC-derived Regenerative Medicine for Heart Failure - BioSpace","headline":"Heartseed Raises $26M in Series B Funding to Accelerate Development of iPSC-derived Regenerative Medicine for Heart Fail","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}